News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Schall Thomas J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G/A
| Schall Thomas J. reports a 6.5% stake in ChemoCentryx, Inc. |
| 01/04/2022 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Paid exercise price by delivering 45,698 shares
@ $36.41, valued at
$1.7M
Exercised 23,334 restricted stock units
@ $0
Exercised 34,567 restricted stock units
@ $0
Exercised 26,333 restricted stock units
@ $0 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 11,153 shares
@ $65.027, valued at
$725.2k
Sold 17,619 shares
@ $65.0122, valued at
$1.1M
Exercised 11,153 options to buy
@ $14.31, valued at
$159.6k
Exercised 17,619 options to buy
@ $14.31, valued at
$252.1k
|
|
| 06/16/2020 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 88,753 shares
@ $65.0781, valued at
$5.8M
Sold 2,000 shares
@ $65.0448, valued at
$130.1k
Exercised 88,753 options to buy
@ $14.31, valued at
$1.3M
Exercised 2,000 options to buy
@ $14.31, valued at
$28.6k
|
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2020 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 119,525 shares
@ $45.1847, valued at
$5.4M
Exercised 119,525 options to buy
@ $14.31, valued at
$1.7M
|
|
| 01/17/2020 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 30,317 shares
@ $41.0057, valued at
$1.2M
Sold 83,556 shares
@ $41.4557, valued at
$3.5M
Sold 22,179 shares
@ $42.1299, valued at
$934.4k
Exercised 30,317 options to buy
@ $10.27, valued at
$311.4k
Exercised 105,735 options to buy
@ $10.27, valued at
$1.1M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 21,641 shares
@ $27.3031, valued at
$590.9k
Sold 14,134 shares
@ $28.4389, valued at
$402k
Sold 31,335 shares
@ $29.2283, valued at
$915.9k
Sold 78,581 shares
@ $30.785, valued at
$2.4M
Sold 32,780 shares
@ $31.7595, valued at
$1M
Sold 14,969 shares
@ $32.6492, valued at
$488.7k
Sold 29,290 shares
@ $33.8557, valued at
$991.6k
Sold 54,936 shares
@ $34.6854, valued at
$1.9M
Sold 1,500 shares
@ $35.5953, valued at
$53.4k
Exercised 279,166 options to buy
@ $6.3, valued at
$1.8M
|
|
| 04/02/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 5,755 shares
@ $14, valued at
$80.6k
Sold 79,259 shares
@ $13.5768, valued at
$1.1M
Sold 74,986 shares
@ $13.8547, valued at
$1M
Exercised 5,755 options to buy
@ $6, valued at
$34.5k
Exercised 79,259 options to buy
@ $6, valued at
$475.6k
Exercised 74,986 options to buy
@ $6, valued at
$449.9k
|
|
| 03/06/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 70,000 restricted stock units
@ $0
Granted 230,000 options to buy
@ $11.02, valued at
$2.5M
|
|
| 02/13/2019 |
SC 13G/A
| Schall Thomas J. reports a 9.1% stake in ChemoCentryx, Inc. |
| 01/14/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 36,762 shares
@ $12.1618, valued at
$447.1k
Exercised 36,762 options to buy
@ $6, valued at
$220.6k
|
|
| 01/09/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 7,275 shares
@ $12.0411, valued at
$87.6k
Sold 12,895 shares
@ $12.0024, valued at
$154.8k
Exercised 7,275 options to buy
@ $6, valued at
$43.7k
Exercised 12,895 options to buy
@ $6, valued at
$77.4k
|
|
| 01/03/2019 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Paid exercise price by delivering 52,806 shares
@ $10.91, valued at
$576.1k
Exercised 33,334 restricted stock units
@ $0
Exercised 33,333 restricted stock units
@ $0
Exercised 30,000 restricted stock units
@ $0 |
|
| 11/09/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 7,211 shares
@ $12.0031, valued at
$86.6k
Exercised 7,211 options to buy
@ $6, valued at
$43.3k
|
|
| 07/02/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 10,757 shares
@ $14.0019, valued at
$150.6k
Sold 100 shares
@ $14.1, valued at
$1.4k
Exercised 10,757 options to buy
@ $6, valued at
$64.5k
Exercised 100 options to buy
@ $6, valued at
$600 |
|
| 05/23/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 16,140 shares
@ $13.004, valued at
$209.9k
Sold 17,798 shares
@ $12.1439, valued at
$216.1k
Sold 30,932 shares
@ $13.0011, valued at
$402.2k
Sold 27,928 shares
@ $13.0082, valued at
$363.3k
Exercised 16,140 options to buy
@ $6, valued at
$96.8k
Exercised 17,798 options to buy
@ $6, valued at
$106.8k
Exercised 30,932 options to buy
@ $6, valued at
$185.6k
Exercised 27,928 options to buy
@ $6, valued at
$167.6k
|
|
| 05/17/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 100,000 shares
@ $11.3206, valued at
$1.1M
Sold 82,202 shares
@ $12.2584, valued at
$1M
Sold 17,798 shares
@ $12.1439, valued at
$216.1k
Exercised 100,000 options to buy
@ $6, valued at
$600k
Exercised 82,202 options to buy
@ $6, valued at
$493.2k
Exercised 17,798 options to buy
@ $6, valued at
$106.8k
|
|
| 05/03/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 17,127 shares
@ $11.0006, valued at
$188.4k
Sold 32,873 shares
@ $11.0258, valued at
$362.5k
Exercised 17,127 options to buy
@ $6, valued at
$102.8k
Exercised 32,873 options to buy
@ $6, valued at
$197.2k
|
|
| 03/07/2018 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 90,000 restricted stock units
@ $0
Granted 290,000 options to buy
@ $10.86, valued at
$3.1M
|
|
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|